Abstract
Clinical Pharmacology & TherapeuticsVolume 96, Issue 2 p. 135-137 Point/Counterpoint Assessment of Tumor Growth Inhibition Metrics to Predict Overall Survival L Claret, L Claret Pharsight Consulting Services, Pharsight, A Certara Company, Marseille, FranceSearch for more papers by this authorR Bruno, Corresponding Author R Bruno rbruno@certara.com Pharsight Consulting Services, Pharsight, A Certara Company, Marseille, FranceSearch for more papers by this author L Claret, L Claret Pharsight Consulting Services, Pharsight, A Certara Company, Marseille, FranceSearch for more papers by this authorR Bruno, Corresponding Author R Bruno rbruno@certara.com Pharsight Consulting Services, Pharsight, A Certara Company, Marseille, FranceSearch for more papers by this author First published: 13 May 2014 https://doi.org/10.1038/clpt.2014.112Citations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume96, Issue2Infectious DiseaseAugust 2014Pages 135-137 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
